Five chemokines were explored in this study, where 3 of them (MCP-1/CCL2, IL-8/CXCL8, and IP-10/CXCL10) showed a significant increase in COVID-19 patients with further increase in higher severities. This evidence concerns the gene CXCL10 and COVID-19.